Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance phase study of PLIVA epoetin versus EPREX in dialysis patients with anemia due to chronic renal failure
2005-003302-28Phase 3Completed
- Sponsor
- PLIVA
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Epoetin alfa RB and epoetin alfa in anemia of renal disease (2 arms), sponsored by PLIVA. Primary endpoints: Equivalent efficacy based on maintenance of hemoglobin levels, Study drug dose requirements and 1 more. Started Aug 2005; status: completed.
02
Drugs
Epoetin alfa RBepoetin alfa
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on 2005-003302-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003302-28.